Japan atherosclerosis society guidelines for prevention of atherosclerotic diseases in Japanese

Japanese Journal of Geriatrics

Volumn 45, Issue 6, 2008, Pages 597-600

  Teramoto, Tamio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERIOSCLEROSIS; CONFERENCE PAPER; FEMALE; HUMAN; JAPAN; MEDICAL SOCIETY; PRACTICE GUIDELINE;

AGED; ARTERIOSCLEROSIS; FEMALE; GUIDELINES AS TOPIC; HUMANS; JAPAN; SOCIETIES, MEDICAL;

EID: 58849124600     PISSN: 03009173     EISSN: None     Source Type: Journal    
DOI: 10.3143/geriatrics.45.597     Document Type: Conference Paper

References (12)

1. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988; 148 (1): 36-69.
2. Japanese source
3. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al.: Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66:1087-1095.
4. Japanese source
5. NIPPON DATA80 Research Group: Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70:1249-1255.
6. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al: Primary prevention of cardiovasculara disease in Japan: Results of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA), Randomized Study with Pravastatin. Lancet 2006; 368:1155-1163.
7. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al: Effects of Eicosapentaenoic acid (EPA) on Major Coronary Events in Hypercholes-terolemic patients: The Japan EPA Lipid Intervention Study (JELIS). Lancet 2007; 369:1090-1098.
8. Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, et al.: Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980-1994. Circ J 2006; 70:960-964.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285 (19): 2486-2497.
10. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, et al: Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Am J Epidemiol 2005; 161:170-179.
11. Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, et al: Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women. Circulation 2008:117.
12. NIPPON DATA80 Research Group: Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70:1249-1255.